• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱导DNA聚合酶活性改变的阿昔洛韦耐药1型单纯疱疹病毒突变体的筛选与鉴定

Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities.

作者信息

Larder B A, Darby G

出版信息

Virology. 1985 Oct 30;146(2):262-71. doi: 10.1016/0042-6822(85)90009-1.

DOI:10.1016/0042-6822(85)90009-1
PMID:2996220
Abstract

A collection of TK+, ACV-resistant mutants of herpes simplex virus type 1 (HSV-1) has been derived using a selection system based on biochemically transformed cells. Evidence is presented suggesting that most of these mutants induce resistant DNA polymerase activities and are thus likely to express variant DNA polymerases. Preliminary data on the pathogenesis of these mutants show that most are similar to wild type virus in the majority of their characteristics, although they may be reduced in their ability to kill mice.

摘要

利用基于生化转化细胞的筛选系统,已获得了一组单纯疱疹病毒1型(HSV-1)的胸苷激酶阳性(TK+)、对阿昔洛韦耐药的突变体。有证据表明,这些突变体中的大多数诱导产生耐药性DNA聚合酶活性,因此可能表达变异的DNA聚合酶。关于这些突变体发病机制的初步数据表明,尽管它们杀死小鼠的能力可能有所降低,但大多数在其大多数特征上与野生型病毒相似。

相似文献

1
Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities.诱导DNA聚合酶活性改变的阿昔洛韦耐药1型单纯疱疹病毒突变体的筛选与鉴定
Virology. 1985 Oct 30;146(2):262-71. doi: 10.1016/0042-6822(85)90009-1.
2
Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities.1型单纯疱疹病毒的阿昔洛韦耐药突变体表现出DNA聚合酶改变或阿昔洛韦磷酸化活性降低。
J Virol. 1981 Dec;40(3):936-41. doi: 10.1128/JVI.40.3.936-941.1981.
3
Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir.单纯疱疹病毒临床分离株对阿昔洛韦的敏感性监测
J Med Virol. 1993;Suppl 1:58-66. doi: 10.1002/jmv.1890410512.
4
Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.免疫功能低下患者体内耐阿昔洛韦的单纯疱疹病毒及其体外研究
Am J Med. 1982 Jul 20;73(1A):387-92. doi: 10.1016/0002-9343(82)90129-2.
5
Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus.单纯疱疹病毒阿昔洛韦耐药突变体的分离与鉴定
J Gen Virol. 1980 Jul;49(1):115-24. doi: 10.1099/0022-1317-49-1-115.
6
Genetic mechanisms of resistance to acyclovir in herpes simplex virus.单纯疱疹病毒对阿昔洛韦耐药的遗传机制。
Am J Med. 1982 Jul 20;73(1A):361-8. doi: 10.1016/0002-9343(82)90123-1.
7
Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1.1型单纯疱疹病毒阿昔洛韦耐药突变体的生化与遗传学分析
Am J Med. 1982 Jul 20;73(1A):351-60. doi: 10.1016/0002-9343(82)90122-x.
8
An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice.一种对阿昔洛韦耐药的2型单纯疱疹病毒毒株,对小鼠具有高度毒性。
Arch Virol. 1988;101(3-4):169-82. doi: 10.1007/BF01310998.
9
Properties of purified enzymes induced by pathogenic drug-resistant mutants of herpes simplex virus. Evidence for virus variants expressing normal DNA polymerase and altered thymidine kinase.单纯疱疹病毒致病性耐药突变体诱导产生的纯化酶的特性。表达正常DNA聚合酶和改变的胸苷激酶的病毒变体的证据。
J Biol Chem. 1983 Feb 10;258(3):2027-33.
10
Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.2型单纯疱疹病毒的临床分离株,可诱导产生底物特异性改变的胸苷激酶。
Antimicrob Agents Chemother. 1987 Jul;31(7):1117-25. doi: 10.1128/AAC.31.7.1117.

引用本文的文献

1
Pharmacokinetics and Safety of Amenamevir in Healthy Subjects: Analysis of Four Randomized Phase 1 Studies.在健康受试者中的氨苯砜药代动力学和安全性:四项随机 I 期研究分析。
Adv Ther. 2017 Dec;34(12):2625-2637. doi: 10.1007/s12325-017-0642-4. Epub 2017 Nov 13.
2
Association between sensitivity of viral thymidine kinase-associated acyclovir-resistant herpes simplex virus type 1 and virulence.病毒胸苷激酶相关的阿昔洛韦耐药1型单纯疱疹病毒的敏感性与毒力之间的关联
Virol J. 2017 Mar 21;14(1):59. doi: 10.1186/s12985-017-0728-2.
3
De Novo Assembly of Human Herpes Virus Type 1 (HHV-1) Genome, Mining of Non-Canonical Structures and Detection of Novel Drug-Resistance Mutations Using Short- and Long-Read Next Generation Sequencing Technologies.
利用短读长和长读长下一代测序技术对人疱疹病毒1型(HHV-1)基因组进行从头组装、挖掘非规范结构并检测新型耐药突变
PLoS One. 2016 Jun 16;11(6):e0157600. doi: 10.1371/journal.pone.0157600. eCollection 2016.
4
Roles of conserved residues within the pre-NH2-terminal domain of herpes simplex virus 1 DNA polymerase in replication and latency in mice.单纯疱疹病毒 1 型 DNA 聚合酶前 NH2 末端结构域中保守残基在复制和潜伏感染小鼠中的作用。
J Gen Virol. 2014 Apr;95(Pt 4):940-947. doi: 10.1099/vir.0.061903-0. Epub 2014 Jan 10.
5
Survey of resistance of herpes simplex virus to acyclovir in northwest England.英格兰西北部单纯疱疹病毒对阿昔洛韦的耐药性调查。
Antimicrob Agents Chemother. 1998 Apr;42(4):868-72. doi: 10.1128/AAC.42.4.868.
6
Related functional domains in virus DNA polymerases.病毒DNA聚合酶中的相关功能结构域。
EMBO J. 1987 Jan;6(1):169-75. doi: 10.1002/j.1460-2075.1987.tb04735.x.
7
Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene.在病毒DNA聚合酶基因中含有耐药性突变的单纯疱疹病毒突变体的致病性。
J Virol. 1986 Oct;60(1):286-9. doi: 10.1128/JVI.60.1.286-289.1986.
8
Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovir.单纯疱疹病毒对阿昔洛韦产生耐药性的致病变体对其他抗疱疹药物的敏感性。
Antimicrob Agents Chemother. 1986 May;29(5):894-8. doi: 10.1128/AAC.29.5.894.
9
An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice.一种对阿昔洛韦耐药的2型单纯疱疹病毒毒株,对小鼠具有高度毒性。
Arch Virol. 1988;101(3-4):169-82. doi: 10.1007/BF01310998.
10
Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.阿昔洛韦。对其抗病毒活性、药代动力学特性及治疗效果的最新综述。
Drugs. 1989 Mar;37(3):233-309. doi: 10.2165/00003495-198937030-00002.